Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives.

 

Everything at Lilly begins with the unmet medical needs of people.  Lilly provides answers for these often complex, difficult problems in two ways: through the discovery and development of breakthrough medicines and through the health information Lilly offers.

 

Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. Lilly collaborates with eminent scientific organizations like FASEB to promote biomedical research.  They employ more than 44,000 people worldwide and market medicines in approximately 143 countries.  Outside the U.S., Lilly has major research and development facilities in nine countries and conducts clinical trials in more than 60 countries.

 

Long-established core values guide Lilly in all that they do.  These values are:

• Respect for people that includes concern for the interests of all people worldwide who touch-or are touched by-the company;

• Integrity that embraces the very highest standards of honesty, ethical behavior, and exemplary moral character;

• Excellence that is reflected in a continuous search for new ways to improve the performance of the business to become the best at what they do.

In this vein, Lilly supports the FASEB Excellence in Science Award & Lecture because, “This award recognizes significant scientific contributions to biological sciences and represents the commitment of Eli Lilly and Company to promoting excellence and diversity in science.”